Verde Bio Holdings Inc (fka VBHI)

[La Dolce Vita]

Be careful what you wish for, as once $APHD gets current, look at all those convertible debentures to contend with:

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12269829

Recent Sales of Unregistered Securities

On February 2, 2017, the Company issued 2,857,923 common shares for the conversion of $2,802 of convertible debenture and $199 of accrued interest.
On February 3, 2017, the Company issued 2,720,000 common shares for the conversion of $1,020 of convertible debenture and $204 of accrued interest.
8
On February 8, 2017, the Company issued 3,137,104 common shares for the conversion of $3,071 of convertible debenture and $223 of accrued interest.
On February 10, 2017, the Company issued 3,100,000 common shares for the conversion of $1,267 of convertible debenture and $128 of accrued interest.
On February 13, 2017, the Company issued 3,293,514 common shares for the conversion of $3,220 of convertible debenture and $238 of accrued interest.
On February 14, 2017, the Company issued 3,600,000 common shares for the conversion of $1,549 of convertible debenture and $71 of accrued interest.
On February 16, 2017, the Company issued 3,612,323 common shares for the conversion of $3,529 of convertible debenture and $264 of accrued interest.
On February 23, 2017, the Company issued 2,550,000 common shares with a fair value of $7,650 pursuant to a consulting agreement dated January 30, 2017. Fair value was based on the closing market price on the date of issuance.
On February 24, 2017, the Company issued 3,972,552 common shares for the conversion of $3,874 of convertible debenture and $297 of accrued interest.
On February 27, 2017, the Company issued 4,295,828 common shares for the conversion of $4,185 of convertible debenture and $326 of accrued interest.
On February 27, 2017, the Company issued 4,298,600 common shares for the conversion of $1,709 of convertible debenture and $225 of accrued interest.
On March 2, 2017, the Company issued 4,727,500 common shares for the conversion of $4,417 of convertible debenture and $50 of accrued interest
On March 2, 2017, the Company issued 4,725,419 common shares for the conversion of $4,600 of convertible debenture and $362 of accrued interest.
On March 6, 2017, the Company issued 2,251,792 common shares for the conversion of $2,500 of convertible debenture and $101 of accrued interest.
On March 8, 2017, the Company issued 4,051,165 common shares for the conversion of $4,700 of convertible debenture and $202 of accrued interest.
On March 3, 2017, the Company issued 4,183,057 common shares for the conversion of $4,071 of convertible debenture and $321 of accrued interest.
On March 3, 2017, the Company issued 4,727,500 common shares for the conversion of $4,452 of convertible debenture and $15 of accrued interest.
On March 3, 2017, the Company issued 4,727,500 common shares for the conversion of $5,082 of convertible debenture.
On March 9, 2017, the Company issued 5,000,000 common shares for the conversion of $5,375 of convertible debenture.
On March 14, 2017, the Company issued 6,000,000 common shares for the conversion of $6,450 of convertible debenture.
On March 13, 2017, the Company issued 4,098,561 common shares for the conversion of $4,750 of convertible debenture and $209 of accrued interest.
On March 14, 2017, the Company issued 6,451,198 common shares for the conversion of $7,475 of convertible debenture and $331 of accrued interest.
On March 16, 2017, the Company issued 6,600,000 common shares for the conversion of $7,092 of convertible debenture.
On March 15, 2017, the Company issued 5,886,400 common shares for the conversion of $5,542 of convertible debenture and $152 of accrued interest
On March 22, 2017, the Company issued 7,600,000 common shares for the conversion of $8,360 of convertible debenture.
On March 23, 2017, the Company issued 6,549,851 common shares for the conversion of $7,575 of convertible debenture and $350 of accrued interest
On March 24, 2017, the Company issued 8,700,000 common shares for the conversion of $9,570 of convertible debenture.
9
On March 16, 2017, the Company issued 6,961,624 common shares for the conversion of $8,521 of convertible debenture.
On March 30, 2017, the Company issued 9,500,000 common shares for the conversion of $10,450 of convertible debenture.
On March 31, 2017, the Company issued 9,350,000 common shares for the conversion of $9,052 of convertible debenture and $204 of accrued interest.
On April 4, 2017, the Company issued 9,500,000 common shares for the conversion of $9,975 of convertible debenture.
On April 13, 2017, the Company issued 10,750,000 common shares for the conversion of $7,139 of convertible debenture and $118 of accrued interest.
On April 13, 2017, the Company issued 10,800,000 common shares for the conversion of $8,100 of convertible debenture.
The foregoing securities were in reliance on an exemption from registration under the Securities Act of 1933 set forth in Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.